{"prompt": "['2016N277425_02', 'CONFIDENTIAL', '2018N377698_00', '201749', 'A spontaneous abortion is always considered to be an SAE and will be reported as', 'such.', 'Any SAE occurring as a result of a post-study pregnancy which is considered', 'reasonably related to the study treatment by the investigator, will be reported to GSK', 'as described in Appendix 4. While the investigator is not obligated to actively seek', 'this information in former study participants, he or she may learn of an SAE through', 'spontaneous reporting.', 'Any female subject who becomes pregnant while participating', 'will be withdrawn from the study', '86']['2016N277425_02', 'CONFIDENTIAL', '2018N377698_00', '201749', '12.8.', 'Appendix 8: Country Specific Requirements', 'No country-specific requirements exist.', '87']['2016N277425_02', 'CONFIDENTIAL', '2018N377698_00', '201749', '12.9.', 'Appendix 9: protocol changes', 'Revision History', '2016N277425_00', '2016-SEP-13', 'Original', '2016N277425_01', '2017-FEB-07', 'Amendment No. 1', '2016N277425_02', '2017-FEB-21', 'Amendment No. 2 Canada', 'only', 'Protocol Amendment 1', 'Scope:', 'This amendment applies to all sites', 'Protocol Changes for Amendment No.1 are summarised below.', 'Strike through text refers to deleted text and underlined refers to added text.', 'Protocol Changes:', 'Title', 'Rationale for change: Correct a typographical error in the title: Umeclidimium to', 'Umeclidinium', 'Regulatory Agency Identifying Number(s):', 'Rationale for change: To correct a typographical error of the EudraCT no. and add an', 'IND no.', 'Revised text:-EudraCT no 2016 002513-226, 2016-002513-22 , IND no. 104479', '88']\n\n###\n\n", "completion": "END"}